Clinical Trial Update: A Study of CC-5013 in the Treatment of Complex Regional Pain Syndrome (CRPS) [Phase 2]

View source ↗

Summary

Phase 2 study of CC-5013 in Complex Regional Pain Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex Regional Pain Syndrome

Drugs mentioned

• Revlimid (lenalidomide)

Snippet

Sponsor: Celgene Corporation | Conditions: Complex Regional Pain Syndrome (RSD) | Phase 2 | Status: COMPLETED